Drug Approval | June 20, 2025
USFDA concludes inspection of NATCO’s Pharma Division, Kothur
The company received seven observations in the Form-483
The company received seven observations in the Form-483
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
The company received one observation in the Form-483
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
The company received 1 (One) observation in the Form-483
Dilip Shanghvi to continue as the Executive Chairman of the Board
This strategic expansion marks a significant step in the company's global growth strategy
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Subscribe To Our Newsletter & Stay Updated
